Jefferies analyst Omotayo Okusanya reiterated a Buy rating on Healthcare Trust (NYSE: HTA) today and set a price target of $34. The company’s shares closed on Friday at $27.96.
According to TipRanks.com, Okusanya is a 4-star analyst with an average return of 7.7% and a 61.8% success rate. Okusanya covers the Financial sector, focusing on stocks such as Apartment Investment & Management, Senior Housing Properties Trust, and Easterly Government Properties.
Healthcare Trust has an analyst consensus of Moderate Buy, with a price target consensus of $30.20, implying an 8.0% upside from current levels. In a report issued on August 3, SunTrust Robinson also reiterated a Buy rating on the stock with a $32 price target.
.
See today’s analyst top recommended stocks >>
Healthcare Trust’s market cap is currently $5.8B and has a P/E ratio of 71.69. The company has a Price to Book ratio of 1.78.
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HTA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Healthcare Trust of America, Inc. operates as an integrated, self-administered and self-managed real estate investment trust. It acquires, owns and operates medical office buildings and other facilities that serve the healthcare industry.
